Analyst Reco.

03-04 Forvia: Resilient FY25 in a Tough Environment; Ambitious 2028 Targets Unveiled at CMD Alphavalue
02-26 Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna… Zonebourse
01-20 Forvia lifts EPS after Q4 pre-close Alphavalue
11-25 Forvia revises EPS outlook after non-cash charge Alphavalue
21/10/25 Forvia: UBS Maintains Neutral Rating After Q3 Revenue in Line with Expectations Zonebourse
21/10/25 Forvia: UBS still neutral after quarterly results Zonebourse
20/10/25 Forvia: Q3 results impacted by geographic mix and FX headwinds; FY25 guidance confirmed Alphavalue
12/09/25 The stock market regains its cloak of invincibility Zonebourse
07/08/25 Forvia: Opinion change, from Sell to Reduce Alphavalue
30/07/25 Analysts' opinions of the day: Kering splits, news on Abivax, Soitec and Novo Nordisk Zonebourse
29/07/25 Forvia: Deutsche Bank downgrades stock Zonebourse
29/07/25 Forvia: Solid H1 results ahead of expectations, FY25 guidance confirmed Alphavalue
29/07/25 Forvia: Oddo BHF raises target price Zonebourse
24/07/25 Forvia: NAV cut by -14.8% Alphavalue
03/07/25 Forvia: Target upgrade by 14.5% Alphavalue
27/06/25 Forvia: Berenberg still a buyer, seeing positive surprises Zonebourse
22/04/25 FORVIA : Receives a Buy rating from Deutsche Bank ZD
22/04/25 Forvia: Oddo BHF lowers target price Zonebourse
17/04/25 Forvia: Stronger than expected Q1 and FY25 guidance maintained despite tariff risks Alphavalue
01/04/25 Forvia: Opinion change, from Buy to Reduce Alphavalue
26/03/25 TP Icap Midcap Kicks Off Forvia Coverage with Hold Rating MT
26/03/25 Forvia: TP ICAP Midcap initiates coverage on hold Zonebourse
19/03/25 FORVIA : UBS reaffirms its Neutral rating ZD
06/03/25 Forvia: Soft FY24 results amid a tough environment, weaker than expected FY25 guidance Alphavalue
24/10/24 Forvia: Forvia posts solid Q3 results amidst a challenging automotive market Alphavalue
No results for this search